Measuring the health benefits and costs of antimicrobial-resistant gonorrhea surveillance in the United States: an agent-based model and cost-effectiveness analysis. - Ekanayake-Weber MS; Rönn MM; Yin X; Hsu K; Li Y; Gift TL; Chesson H; Frankson R; Salomon JA; Grad YH; Yaesoubi R (Lancet regional health. Americas, 2026)